(Q44648434)

English

Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Heart failure with preserved ejection fraction

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1

object named as

Savina Nodari

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

3

object named as

Livio Dei Cas

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

621-627

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Prognostic significance of left ventricular diastolic dysfunction in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Nitric oxide mediated venodilator effects of nebivolol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Effects of antihypertensive drugs on endothelial dysfunction: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

NO and cardiac diastolic function.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Pharmacological properties of nebivolol in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Exercise and antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: A comparison between alpha blockers and different types of beta blockers with and without vasodilating effect

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

21 January 2018

Diastolic heart failure: neglected or misdiagnosed?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

ACE Inhibitors for ‘Diastolic’ Heart Failure? Reasons not to jump to premature conclusions about the efficacy of ACE inhibitors among older patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Nebivolol induces NO-mediated relaxations of rat small mesenteric but not of large elastic arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Basal release of nitric oxide augments the Frank-Starling response in the isolated heart

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of NO donors on LV diastolic function in patients with severe pressure-overload hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic effects of nebivolol at rest and on exertion in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

How to diagnose diastolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining diastolic heart failure: a call for standardized diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged kinetics of recovery of oxygen consumption after maximal graded exercise in patients with chronic heart failure. Analysis with gas exchange measurements and NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of nebivolol on left ventricular hypertrophy in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900054-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1388-9842(03)00054-0

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44648434&oldid=2111356793"